Shiva Pharmachem Ltd - Stock Valuation and Financial Performance

BSE: 0 | NSE: | Chemicals | Small Cap

BSE Share Price
Not Listed

DeciZen - make an informed investing decision on Shiva Pharmachem

DeciZen not available for IPO

10 Year X-Ray of Shiva Pharmachem:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation

Value Creation Index Colour Code Guide

Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
ROCE % 19.2%7.2%7.2%1.7%4.4%19%30.2%15.3%15.1%14.6%-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 490470413422495706640528709762706
Sales YoY Gr.--4.2%-12.1%2.1%17.3%42.6%-9.4%-17.5%34.3%7.5%-
Adj EPS 2.71.30.9-0.80.15.911.866.67.70
YoY Gr.--53.1%-27.3%-180.7%NA6466.7%99.5%-49.2%10%17.2%-
BVPS (₹) 10.1111211.111.617.523.127.234.242.60
Adj Net
Profit
28.513.49.7-7.9161.712363.67082NAN
Cash Flow from Ops. 0.810483.640.851.970.2108172-0.187.4-
Debt/CF from Ops. 157.72.13.26.15.13.32.10.9-1944.12.4-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 5%9%6%7.5%
Adj EPS 12.2%143.6%-13.2%17.2%
BVPS17.3%29.8%22.6%24.4%
Share Price - - - -

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
Return on
Equity %
30.612.18.1-6.50.840.758.12421.520.10
Op. Profit
Mgn %
131013.39.31016.425.520.218.620.4NAN
Net Profit
Mgn %
5.82.82.4-1.90.28.719.212.19.910.8NAN
Debt to
Equity
1.21.92.12.12.21.30.90.50.50.5-
Working Cap
Days
971281691831681451852111842140
Cash Conv.
Cycle
5471931161118495111991260

Recent Performance Summary

Recent Performance Summary not available for IPO

Recent Performance Summary not available for IPO

Latest Financials - Shiva Pharmachem Ltd.

Standalone Consolidated
TTM EPS (₹) 0 -
TTM Sales (₹ Cr.) 706 -
BVPS (₹.) 0 -
Reserves (₹ Cr.) 175 -
P/BV 0.00 -
PE 0.00 -
From the Market
52 Week Low / High (₹) - / -
All Time Low / High (₹) - / -
Market Cap (₹ Cr.) 0
Equity (₹ Cr.) 0
Face Value (₹) -
Industry PE 49.3

Management X-Ray of Shiva Pharmachem:

Shareholding Pattern

No Data To Display

Promoter's Holding & Share Pledging

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Shiva Pharmachem

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Sales490.34469.96413.21421.97495.06705.87639.81527.74708.61761.70
Operating Expenses 426.83422.94358.47382.54445.67590.29476.67421.05576.65606.22
Manufacturing Costs15.2512.6914.4926.9724.5432.3041.9636.5367.0175.50
Material Costs378.29353.29268.92284.40334.75455.41323.14270.35375.63384.62
Employee Cost 11.9715.5228.4833.8937.6041.3547.5055.4765.4868.03
Other Costs 21.3341.4546.5837.2848.7861.2364.0758.7068.5378.07
Operating Profit 63.5147.0154.7439.4249.39115.58163.14106.69131.96155.48
Operating Profit Margin (%) 13.0%10.0%13.2%9.3%10.0%16.4%25.5%20.2%18.6%20.4%
Other Income 3.675.9010.288.5612.328.7837.8615.3712.6812.98
Interest 15.349.9623.1320.5222.3920.7814.117.456.679.73
Depreciation 8.4519.0827.7234.6137.3732.882822.6037.3235.48
Exceptional Items 0-0.330000-0.87000
Profit Before Tax 43.3823.5414.17-7.151.9470.70158.0192.01100.65123.25
Tax 14.788.240-1.85-2.788.9429.2624.2725.9434.13
Profit After Tax 28.5915.3014.17-5.304.7361.76128.7567.7474.7189.12
PAT Margin (%) 5.8%3.3%3.4%-1.3%1.0%8.7%20.1%12.8%10.5%11.7%
Adjusted EPS (₹)2.71.51.4-0.50.55.912.46.47.08.4
Dividend Payout Ratio (%)12%23%22%-66%0%0%15%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23

Equity and Liabilities

Shareholders Fund 105.43114.87125.28115.80120.53182.28240.60288.99363.37452.14
Share Capital 6.956.956.956.956.956.956.957.087.0821.24
Reserves 98.48107.92118.33108.85113.58175.33233.65281.91356.29430.90
Minority Interest0000000000
Debt128.04191.95240.04224.20240.82212.78210.59148.92176.08198.25
Long Term Debt45.7578.4991.1068.6575.9366.2356.4750.3434.499.38
Short Term Debt82.29113.46148.94155.55164.90146.55154.1298.58141.59188.87
Trade Payables37.4331.4542.382943.0680.1545.7357.0184.2064.57
Others Liabilities 16.3333.3842.5439.8437.0248.0644.9850.5874.8674.31
Total Liabilities 287.23371.65450.24408.85441.43523.27541.89545.50698.50789.28

Fixed Assets

Gross Block104.39159.75231.50285.53311.27329.10289.39371.26413.05449.39
Accumulated Depreciation33.3646.3574.07108.76145.39177.87176.89198.18234.71269.85
Net Fixed Assets71.03113.39157.42176.77165.88151.23112.50173.08178.34179.54
CWIP 47.5653.9926.025.932.5819.1153.4735.5040.2884.01
Investments 0.170.8412.6112.6112.6620.2828.7540.0940.9957.42
Inventories28.9238.4850.6055.9148.3877.4863.4574.01108.34102.65
Trade Receivables104.8198.03118.88118.60160.78191.35179.64142.39234.12273.87
Cash Equivalents 10.6719.2241.772.4916.3015.2616.3317.765.017.42
Others Assets24.0747.6942.9436.5334.8648.5687.7562.6691.4284.37
Total Assets 287.23371.65450.24408.85441.43523.27541.89545.50698.50789.28

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Cash Flow From Operating Activity 0.81104.4683.6340.8351.9170.18108.09172.18-0.1087.38
PBT 43.3823.8614.17-7.151.9470.70158.0192.01100.65123.25
Adjustment 22.7828.2650.5454.6359.5551.9823.6928.0441.5840.01
Changes in Working Capital -34.6360.5824.94-1.4-20.18-11.12-3.4882.1-142.33-75.88
Tax Paid -15.37-8.24-6-5.250-11.82-31.12-29.9700
Cash Flow From Investing Activity -40.48-82.35-55.55-33.87-23.17-42.39-32.11-68.63-47.30-92.91
Capex -40.48-81.68-43.78-33.87-23.13-34.77-23.64-71.14-47.27-80.55
Net Investments 0-0.67-11.7800000.04-0.90-12.42
Others -0.01000-0.05-7.62-8.482.480.870.06
Cash Flow From Financing Activity 31.52-13.56-5.53-46.55-14.93-28.83-74.92-99.9936.457.94
Net Proceeds from Shares 0000000.13000
Net Proceeds from Borrowing 00000000-15.85-25.11
Interest Paid -0.8800-20.460.211.681.99-7.45-5.73-9.10
Dividend Paid -3.48-3.48-3.13-3.4800-23.46000
Others 35.87-10.08-2.40-22.62-15.13-30.51-53.57-92.5458.0342.14
Net Cash Flow -8.168.5522.55-39.5913.81-1.041.063.56-10.952.40
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Ratios
ROE (%)30.6913.8911.8-4.4440.7960.8925.5822.9121.86
ROCE (%)28.7511.8910.333.546.522.8539.1822.0721.6321.89
Asset Turnover Ratio2.011.481.040.981.161.461.20.971.141.02
PAT to CFO Conversion(x)0.036.835.9N/A10.971.140.842.54-00.98
Working Capital Days
Receivable Days6576921031039110611197122
Inventory Days19253846383340484751
Payable Days33365046394971696971

Shiva Pharmachem Ltd Stock News

Shiva Pharmachem Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Shiva Pharmachem on 01-Jan-1970 05:30 is ₹0.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 01-Jan-1970 05:30 the market cap of Shiva Pharmachem stood at ₹0.00.
The latest P/E ratio of Shiva Pharmachem as of 01-Jan-1970 05:30 is 0.00.
The latest P/B ratio of Shiva Pharmachem as of 01-Jan-1970 05:30 is 0.00.
The 52-week high of Shiva Pharmachem is ₹0.00 and the 52-week low is ₹0.00.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Shiva Pharmachem is ₹705.9 ( Cr.) .

About Shiva Pharmachem Ltd

No data to display
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.